The serious complications of GLP-1s that few may know about
November 17, 2026

(Washington Post) – With millions of patients taking GLP-1 drugs, doctors are discovering rare but worrying problems affecting the body and the mind.
But as the lawsuits move through the courts, they are putting a difficult question at the center of the GLP-1 revolution: When millions of people are taking relatively new drugs, how much evidence of a rare but devastating risk is enough to require a warning?
Here’s what the latest research tells us about the potential risks of GLP-1 drugs — and what remains unknown. (Read More)